Antonova O A, Shustova O N, Golubeva N V, Yakushkin V V, Alchinova I B, Karganov M Y, Mazurov A V
National Medical Research Center for Cardiology, Moscow, Russia.
Institute of General Pathology and Pathophysiology, Moscow, Russia.
Biomed Khim. 2019 Apr;65(3):214-221. doi: 10.18097/PBMC20196503214.
Membrane microparticles (MP) produced upon cell activation and/or damage possess coagulation activity, i.e. ability to accelerate blood clotting. They contain on their surface phosphatidylserine (PS), a substrate for assembling coagulation enzymatic complexes, and some of them tissue factor (TF), the initiator of clotting cascade reactions. In this study coagulation properties of MP derived from erythrocytes have been investigated. These MP were obtained from donor's erythrocytes activated with ionophore A23187 as well as from outdated erythrocyte concentrates for transfusion. MP were counted by flow cytometry. Coagulation activity of MP was examined by modified plasma recalcification assay. Involvement of PS and TF in this reaction was assessed using PS blocker lactadherin and anti-TF antibodies. TF activity in MP was measured by its ability to activate factor X in a chromogenic assay. Size of MP was evaluated by dynamic light scattering. Properties of erythrocyte MP were compared with previously characterized (using the same methodological approaches) MP derived from platelets and monocytic THP-1 cells, lacking and containing TF, respectively. Erythrocyte MP accelerated plasma clotting, but less actively than MP from platelets and MP from THP-1 cells, which demonstrated maximal activity. Lactadherin completely inhibited coagulation activity of all MP. Anti-TF antibodies did not affect clotting parameters in the presence of platelet and erythrocyte MP, but slowed clotting in the presence of MP from THP-1 cells. TF activity was not detected in erythrocyte and platelet MP, unlike MP from THP-1 cells expressing active TF. MP derived from erythrocytes were smaller than MP from platelets and THP-1 cells, with average diameter about 200 nm and 400 nm respectively. Thus, MP from erythrocyte possess less ability to accelerate plasma clotting in comparison with MP from platelet and THP-1 cells. The data obtained suggest that lesser coagulation activity of erythrocyte MP in comparison with MP from THP-1 cells is due to the absence of TF in erythrocyte MP (in contrast to MP from THP-1 cells) and to their smaller size, and in comparison with MP from platelets (which as erythrocyte MP do not express TF) is due to their smaller size only.
细胞激活和/或损伤时产生的膜微粒(MP)具有凝血活性,即加速血液凝固的能力。它们的表面含有磷脂酰丝氨酸(PS),这是组装凝血酶复合物的底物,其中一些还含有组织因子(TF),即凝血级联反应的启动因子。在本研究中,对来源于红细胞的MP的凝血特性进行了研究。这些MP取自用离子载体A23187激活的供体红细胞以及过期的输血用红细胞浓缩液。通过流式细胞术对MP进行计数。用改良的血浆复钙试验检测MP的凝血活性。使用PS阻断剂乳黏附素和抗TF抗体评估PS和TF在该反应中的作用。通过其在显色测定中激活因子X的能力来测量MP中的TF活性。通过动态光散射评估MP的大小。将红细胞MP的特性与先前表征的(使用相同方法)分别来源于血小板和单核细胞THP - 1细胞的MP进行比较,后者分别不含TF和含有TF。红细胞MP加速血浆凝固,但活性低于血小板MP和THP - 1细胞MP,后者表现出最大活性。乳黏附素完全抑制了所有MP的凝血活性。抗TF抗体在存在血小板和红细胞MP时不影响凝血参数,但在存在THP - 1细胞MP时减缓了凝血。与表达活性TF的THP - 1细胞MP不同,在红细胞和血小板MP中未检测到TF活性。来源于红细胞的MP比血小板和THP - 1细胞的MP小,平均直径分别约为200nm和400nm。因此,与血小板和THP - 1细胞的MP相比,红细胞MP加速血浆凝固的能力较弱。所获得的数据表明,与THP - 1细胞的MP相比,红细胞MP的凝血活性较低是由于红细胞MP中不存在TF(与THP - 1细胞的MP相反)以及它们较小的尺寸,而与血小板的MP(其与红细胞MP一样不表达TF)相比则仅由于其较小的尺寸。